Skip to main content
Home
  • ALL Specialities ALL Specialities
    Home
    Home

    Error message

    • Deprecated function: Return type of DatabaseStatementBase::execute($args = [], $options = []) should either be compatible with PDOStatement::execute(?array $params = null): bool, or the #[\ReturnTypeWillChange] attribute should be used to temporarily suppress the notice in require_once() (line 2246 of /var/www/webmd/apps/mdedge/htdocs/includes/database/database.inc).
    • Deprecated function: Return type of DatabaseStatementEmpty::current() should either be compatible with Iterator::current(): mixed, or the #[\ReturnTypeWillChange] attribute should be used to temporarily suppress the notice in require_once() (line 2348 of /var/www/webmd/apps/mdedge/htdocs/includes/database/database.inc).
    • Deprecated function: Return type of DatabaseStatementEmpty::next() should either be compatible with Iterator::next(): void, or the #[\ReturnTypeWillChange] attribute should be used to temporarily suppress the notice in require_once() (line 2348 of /var/www/webmd/apps/mdedge/htdocs/includes/database/database.inc).
    • Deprecated function: Return type of DatabaseStatementEmpty::key() should either be compatible with Iterator::key(): mixed, or the #[\ReturnTypeWillChange] attribute should be used to temporarily suppress the notice in require_once() (line 2348 of /var/www/webmd/apps/mdedge/htdocs/includes/database/database.inc).
    • Deprecated function: Return type of DatabaseStatementEmpty::valid() should either be compatible with Iterator::valid(): bool, or the #[\ReturnTypeWillChange] attribute should be used to temporarily suppress the notice in require_once() (line 2348 of /var/www/webmd/apps/mdedge/htdocs/includes/database/database.inc).
    • Deprecated function: Return type of DatabaseStatementEmpty::rewind() should either be compatible with Iterator::rewind(): void, or the #[\ReturnTypeWillChange] attribute should be used to temporarily suppress the notice in require_once() (line 2348 of /var/www/webmd/apps/mdedge/htdocs/includes/database/database.inc).

    Susan London

    News

    Two different radiation boost strategies reduce local failures in NSCLC

    Author:
    Susan London
    Publish date: December 24, 2020

    The two strategies – one delivering a boost to the whole tumor and the other delivering a boost only to the...

    • Read More

    News

    Long-term APBI cosmetic, toxicity data reported

    Author:
    Susan London
    Publish date: December 23, 2020

    Compared with whole-breast irradiation, APBI delivered with 3D-conformal radiotherapy yielded slightly poorer 5-...

    • Read More

    News

    Pregnancy after breast cancer is rockier but doesn’t increase recurrence risk

    Author:
    Susan London
    Publish date: December 11, 2020

    Compared with the general population, breast cancer survivors were less likely to conceive and more likely to...

    • Read More

    News

    Focal radiation boost nets better outcomes in prostate cancer

    Author:
    Susan London
    Publish date: December 10, 2020

    Adding a boost to the visible tumor on MRI reduced the 5-year risk of biochemical recurrence or death by nearly half, without increasing late...

    • Read More

    News

    Breast surgery may be a gateway to addictive medication use

    Author:
    Susan London
    Publish date: December 9, 2020

    More than 13% of women who underwent a mastectomy with reconstruction became persistent users of opioids and/or sedative-hypnotic drugs thereafter...

    • Read More

    News

    ‘Impressive’ results with neoadjuvant T-VEC in advanced melanoma

    Author:
    Susan London
    Publish date: December 7, 2020

    Superior outcomes with intralesional T-VEC plus surgery persisted at 3 years.

    • Read More

    News

    Immune checkpoint inhibitors don’t increase COVID-19 incidence or mortality, studies suggest

    Author:
    Susan London
    Publish date: November 25, 2020

    Cancer patients treated with immune checkpoint inhibitors are not significantly more likely to develop or die from COVID-19, two studies suggest...

    • Read More

    News

    Neoadjuvant immunotherapy combo produces high response rate in melanoma

    Author:
    Susan London
    Publish date: November 25, 2020

    Final results of the Neo-C-Nivo trial show a 70% pathologic response rate in patients with high-risk resectable...

    • Read More

    News

    Immunotherapy could fill unmet need in leptomeningeal metastases

    Author:
    Susan London
    Publish date: November 20, 2020

    More than a third of patients had a CNS response to systemically administered pembrolizumab, including two patients who had long-lived complete...

    • Read More

    News

    Risk factors for severe immune-related AEs identified

    Author:
    Susan London
    Publish date: November 19, 2020

    A nationwide cohort study of more than 14,000 patients finds combination immune checkpoint inhibitor therapy, younger age, and a lung cancer...

    • Read More

    News

    Predictors of upstaging on PSMA PET/CT may help guide its use

    Author:
    Susan London
    Publish date: November 16, 2020

    Patients with high-risk prostate cancer having more positive cores on biopsy or a higher Gleason grade were most likely to experience upstaging...

    • Read More

    News

    Lung cancer: Proton beam radiotherapy likely reduces cardiovascular events

    Author:
    Susan London
    Publish date: November 13, 2020

    A retrospective study shows lower rates of transient ischemic attack and MI with proton beam radiotherapy.

    • Read More

    News

    Family planning issues loom large for female radiation oncologists

    Author:
    Susan London
    Publish date: November 3, 2020

    Nearly three-quarters of survey respondents said their career choice strongly influenced when they started or planned to start their family.

    • Read More

    News

    Molecular features of medulloblastoma may help personalize radiotherapy

    Author:
    Susan London
    Publish date: November 2, 2020

    The impact of different radiation-reducing strategies varied across four molecular subgroups.

    • Read More

    News

    PET guidance for radiation therapy improves prostate cancer outcomes

    Author:
    Susan London
    Publish date: October 29, 2020

    Using PET as well as conventional imaging to guide postprostatectomy radiation therapy reduces the risk of treatment failure.

    • Read More

    Pages

    • « first
    • 1
    • 2
    • 3
    • 4
    • 5
    • 6
    • 7
    • 8
    • 9
    • …
    • last »

    Privacy Policy

    Terms of Use

    Editorial Policy

    Cookie Policy

    Ad Policy

    Medscape Customer Support

    Frequently Asked Questions

     

    Advertise with MDedge

    See more with MDedge! See our Other Publications

    MDedge: Keeping You Informed. Saving You Time.

    Copyright  © 2023 Frontline Medical Communications Inc., 283-299 Market Street, 2 Gateway Center, 4th Floor, Newark, NJ 07102. All rights reserved. Unauthorized use prohibited. The information provided is for educational purposes only. Use of this Web site is subject to the medical disclaimer.

    • All Specialties